Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Sanofi crawled date : 2022 - 09 - 15 save search
Positive Dupixent® (dupilumab) Phase 3 Data in Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis Published in The Lancet
Published: 2022-09-15 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.74%
H: 0.91%
C: -0.74%
SNY | News | $45.41 -1.52% 4.3M
|
Health Technology
|
| O: -0.52%
H: 0.0%
C: 0.0%
REGN | $897.35 -0.43% 240K
|
Health Technology
|
| O: 0.62%
H: 1.12%
C: 0.01%
dupixent children lancet dermatitis positive
New Jersey To Celebrate Year of Women in Manufacturing at 10th Annual 'MADE in New Jersey' Manufacturing Day
Published: 2022-09-15 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.74%
H: 0.91%
C: -0.74%
SNY | News | $45.41 -1.52% 4.3M
|
Health Technology
|
| O: -0.52%
H: 0.0%
C: 0.0%
day women year
Worldwide Irritable Bowel Syndrome with Constipation Drugs Industry to 2030 - by Drug Type, Prescription Type and Region
Published: 2022-09-15 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -6.5%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: -3.99%
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 0.22%
H: 0.14%
C: -0.43%
ABT | News | $105.28 -0.59% 0.0% 7.3M
|
Health Technology
|
| O: 0.26%
H: 0.96%
C: -0.94%
SNY | News | $45.41 -1.52% 4.3M
|
Health Technology
|
| O: 0.4%
H: 0.84%
C: 0.37%
IRWD | $7.605 -0.59% 2.4M
|
Health Technology
|
| O: 0.0%
H: 0.72%
C: -1.27%
AZN | $68.38 -0.22% 2.3M
|
Health Technology
|
| O: -0.19%
H: 0.09%
C: -0.8%
ARDX | $6.445 -1.6% -1.63% 3.5M
|
Health Technology
|
| O: -2.9%
H: 3.73%
C: 2.24%
drug
BioNJ Releases Speakers and Agenda for 2022 C-Suite Summit
Published: 2022-09-15 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -6.5%
SNY | News | $45.41 -1.52% 4.3M
|
Health Technology
|
| O: 0.4%
H: 0.84%
C: 0.37%
YOOBIC Celebrates Banner Year in North America With Accelerating Global Growth
Published: 2022-09-15 (Crawled : 14:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -6.5%
SNY | News | $45.41 -1.52% 4.3M
|
Health Technology
|
| O: 0.4%
H: 0.84%
C: 0.37%
america global year growth
Experimental Test Promises to Predict Side-Effects and Cancer's Return in Patients Treated with Immunotherapy
Published: 2022-09-15 (Crawled : 14:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -6.5%
SNY | News | $45.41 -1.52% 4.3M
|
Health Technology
|
| O: 0.4%
H: 0.84%
C: 0.37%
immunotherapy test cancer
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
Published: 2022-09-15 (Crawled : 13:20) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -6.5%
SNY | News | $45.41 -1.52% 4.3M
|
Health Technology
|
| O: 0.4%
H: 0.84%
C: 0.37%
therapeutics
Regeneron and Alnylam Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers
Published: 2022-09-15 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -6.5%
SNY | News | $45.41 -1.52% 4.3M
|
Health Technology
|
| O: 0.4%
H: 0.84%
C: 0.37%
REGN | $897.35 -0.43% 240K
|
Health Technology
|
| O: -0.41%
H: 3.27%
C: 1.6%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -0.9%
H: 2.16%
C: 1.01%
ongoing report nash study phase 1
Alnylam and Regeneron Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers
Published: 2022-09-15 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -6.5%
SNY | News | $45.41 -1.52% 4.3M
|
Health Technology
|
| O: 0.4%
H: 0.84%
C: 0.37%
REGN | $897.35 -0.43% 240K
|
Health Technology
|
| O: -0.41%
H: 3.27%
C: 1.6%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -0.9%
H: 2.16%
C: 1.01%
ongoing report nash study phase 1
Innate Pharma Reports First Half 2022 Financial Results and Business Update
Published: 2022-09-15 (Crawled : 06:00) - biospace.com/
BNPQF | News 6 d | $68.558 -13.4% 400
|
Finance
|
| O: -1.65%
H: 0.0%
C: -2.85%
BNPQY | News 6 d | $34.25 -2.68% 180K
|
Finance and Insurance
|
| O: -1.12%
H: 2.34%
C: 1.69%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -6.5%
NVO | News | $122.675 -1.49% 2.1M
|
Health Technology
|
| O: -0.88%
H: 0.45%
C: -0.87%
SNY | News | $45.41 -1.52% 4.3M
|
Health Technology
|
| O: 0.4%
H: 0.84%
C: 0.37%
IPHA | $2.41 11K
|
Health Technology
|
| O: 3.25%
H: 0.0%
C: 0.0%
pharma financial update results
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M
|
Finance
ISPC | $0.4621 116.95% 15M
|
Professional, Scientific, and T...
INVO | $1.515 99.34% 4.3M
|
Health Technology
WLGS | $0.92 84.0% 45.65% 900K
|
ZCMD | $2.44 78.1% 43.85% 330K
|
Commercial Services
XPON | $3.1 60.62% 37.74% 16M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
PRTG | $0.299 35.17% 120K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.